Place of Glifl ozin in advanced heart failure
J.-S. HULOT
Deteriorated care in heart failure patients during Covid
P. NHAN
Guidelines and amyloidosis
S. GUENDOUZ
Dobutamine at home in Intermacs 3 patient: Experience in Lyon
L. SEBBAG
Management of secondary mitral insuffi ciency: recent recommendations
J.-F. OBADIA
Levosimendan and Ecmo withdrawal
J. MASSOL
Heart and lung transplants in 2020: update from the Biomedecine Agency
R. DORENT
Out of protocol Allocation of cardiac grafts: limits and organization
R. DORENT
The forgotten of the score DVDA, CMR, CMH
- La Pitié
G. COUTANCE
- The Biomedecine Agency
R. DORENT
Excluded from the score: potential recipient with a predicted mortality > 50%
Stratification of the death risk after heart transplantation: situation-specifi c scores or generalized score
Remote monitoring systems in organ transplantation
- Cibiltech
O. AUBERT
Clinical case: a very bad mood rejection
G. COUTANCE
Molecular pathology in heart transplantation
- Pathologist’s point of view: the limits of the current classification of rejection and first experiences in heart transplantation
J.-P. DUONG-VAN-HUYEN
- The clinician’s point of view: molecular diagnosis as an integral part of rejection diagnosis in renal transplantation - development of a molecular biology platform
A. LOUPY
- Discussion
Maastricht III heart: where do we stand?
C. ANTOINE
Induction treatment in heart transplantation: different practices in France
G. COUTANCE
Induction cooking
E. EPAILLY
Discussion
Cardiac catheterism and renal function: predictive factors of renal function after cardiac transplantation
G .BAUDRY
Monitoring of quantiferon CMV in post heart transplant follow-up
K. SERMET
Status of the Allomap study
L. SEBBAG
Cardiac transplantation in patients with infected long term MCS
E. DESIRE
Letermovir: what place against CMV in heart transplantation?
A. BOIGNARD
09.00
18.00
Coordination Francophone pour le Développement de l’Assistance Cardiaque (COFDAC)
The cooperation protocol: where do we stand in France?
M. KINDO, M. TYMAN
When LVAD gets old socially…
M. BERTINOT
The psychologist’s role in the heart team
When we simulate in Lille...
Management of VKA in hospitals: Who takes care of it? How?
The general practitioner in the management of LVAD patients: How can we involve them more?
Position of the VAD coordinator in the Heart Team
Management of phone calls: VAD coordinator skills
Stratification of cardiogenic shock
N. AISSAOUI
Medical management of cardiogenic shock
P. LIM
Focus on different «mechanical» strategies in the treatment of cardiogenic shock
P. LEPRINCE
ECMO: results by etiology
G. LEBRETON
Interactive clinical case
C. JUVIN
Heart and lung transplants in 2020: the ABM update
R. DORENT
Cardiac graft vasculopathy
G. COUTANCE
Implementation of a heart transplant patient’s follow-up booklet
O. CAZIMAJOU, L.GASPARD
Graft perfusion system
- Heart
G. LEBRETON
- Lung
E. SAGE
Diabetes in heart transplant patients
O. BOURRON
Covid Vaccination and Organ Transplantation
- Covid vaccination in solid organ transplant patients: why and how
B. BARROU
- Efficiency of vaccination for heart transplant patients
F. HAZAN, E. TODESCO
- Discussion
Quality of life in heart transplant patients
S. JAMET, L. COURTINE
Clinicale cas
G. COUTANCE, F. HAZAN
ECMO in COVID patients: organization and outcome
G. LEBRETON
Rapid rehabilitation after MCS implantation: rational and organization
M. KINDO
Surgical technique: Two HeartMate3 as a total artifi cial heart (HeartMate 6)
M. MORAND, L. JODAR ALVES
HM3 Care giver training on simulator
C. BLONDEAU
Transplant patients’ Association of the Pitié-Salpêtrière Hospital: action point
J. CAMUS, M. BOURGEOIS
COFDAC update
V. DESRIAC
ECMO VV COVID: evolution of the prognosis 1st /2nd wave
M. SCHMIDT
Comparison of the effects of Impella and ECMO in an animal model
S. MANZO-SILBERMAN
Ecpella (preliminary data): ultrasound update
N. HAMMOUDI
Interest of viscoelastic monitoring of coagulation in patients under ECMO
C. FRERE
TX under ECMO: impact on resources involved and patient recovery
G. COUTANCE
VA ECMO: 5-year outcome according to etiology
G. LEBRETON
Circulatory support in fulminant myocarditis patients: results of an international cohort (The FULLMOON study)
M. SCHMIDT
Status of the long-term mechanical circulatory support devices 2015-2021
M. KINDO
Cardiomems and LVAD
G. LEBRETON
AF surgical ablation and heart failure
M. LA MEIR
Destination therapy: another French exception?
F. VANHUYSE
Percutaneous deactivation of LVADs in the «Bridge to recovery» strategy: Preliminary Experience
M. POZZI
Optimal preparation of ambulatory candidate to LVAD implantation
G. BAUDRY
Importance of the Aorta to PA ratio on CT in predicting right-sided failure
K. BOUNADER
DOA and LVAD
P. BATTISTELLA
Euromacs Registry and interface with Francemacs
T. de BY
My greatest success, my most bitter failure
P. BATTISTELLA, S. MEJEAN
A. SEBESTYEN
Cardiac graft perfusion
- Transmedics
A. VINCENTELLI
- Xvivo
G. LEBRETON
Discussion
Abiomed
J. FLECHE
CorWave Update
C. RASSER
Résultats in vivo à 1 mois et 2 mois sans drive-line du système ICOMS FineHeart
K. NUBRET
Carmat
C. LATREMOUILLE
Abbott
T. NYIKOS
Syncardia
D. TEO